Cargando…

Specific gene expression signatures of low grade meningiomas

INTRODUCTION: Meningiomas are the most common primary central nervous system (CNS) tumors in adults, representing approximately one-third of all primary adult CNS tumors. Although several recent publications have proposed alternative grading systems of meningiomas that incorporate genomic and/or epi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsitsikov, Erdyni N., Hameed, Sanaa, Tavakol, Sherwin A., Stephens, Tressie M., Tsytsykova, Alla V., Garman, Lori, Bi, Wenya Linda, Dunn, Ian F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016690/ https://www.ncbi.nlm.nih.gov/pubmed/36937440 http://dx.doi.org/10.3389/fonc.2023.1126550

Ejemplares similares

Mutated KLF4(K409Q) in meningioma binds STRs and activates FGF3 gene expression
por: Tsytsykova, Alla V., et al.
Publicado: (2022)

TRAF7 is an essential regulator of blood vessel integrity during mouse embryonic and neonatal development
por: Tsitsikov, Erdyni N., et al.
Publicado: (2023)

COMMD10 Is Essential for Neural Plate Development during Embryogenesis
por: Phan, Khanh P., et al.
Publicado: (2023)

Cyst Type Differentiates Rathke Cleft Cysts From Cystic Pituitary Adenomas
por: Tavakol, Sherwin, et al.
Publicado: (2021)

A molecularly integrated grade for meningioma
por: Driver, Joseph, et al.
Publicado: (2021)

Gene Expression Signatures Identify Biologically Homogenous Subgroups of Grade 2 Meningiomas
por: Zador, Zsolt, et al.
Publicado: (2020)

The Discrepancy Between Standard Histologic WHO Grading of Meningioma and Molecular Profile: A Single Institution Series
por: Roehrkasse, Amanda M., et al.
Publicado: (2022)

Genomic landscape of high-grade meningiomas
por: Bi, Wenya Linda, et al.
Publicado: (2017)

Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications
por: Bi, Wenya Linda, et al.
Publicado: (2016)

Erratum: Genomic landscape of high-grade meningiomas
por: Bi, Wenya Linda, et al.
Publicado: (2017)

Genomic profile of human meningioma cell lines
por: Mei, Yu, et al.
Publicado: (2017)

Radiation Treatment for WHO Grade II and III Meningiomas
por: Walcott, Brian P., et al.
Publicado: (2013)

Recurrence/Regrowth in Grade I Meningioma: How to Predict?
por: de Carvalho, Gervásio Teles Cardoso, et al.
Publicado: (2020)

Radiographic prediction of meningioma grade by semantic and radiomic features
por: Coroller, Thibaud P., et al.
Publicado: (2017)

Analysis of Prognostic Factors of World Health Organization Grade Ⅲ Meningiomas
por: Tian, Weidong, et al.
Publicado: (2020)

Editorial: Meningioma: From basic research to clinical translational study, volume II
por: Tang, Hailiang, et al.
Publicado: (2023)

Intracranial Grade II Meningioma Oligometastatic to the Cervical Spine
por: Natarajan, Jyotsna M, et al.
Publicado: (2021)

Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma
por: Wang, Daijun, et al.
Publicado: (2020)

The efficacy of preoperative MRI features in the diagnosis of meningioma WHO grade and brain invasion
por: Jiang, Jun, et al.
Publicado: (2023)

Predicting the grade of meningiomas by clinical–radiological features: A comparison of precontrast and postcontrast MRI
por: Yao, Yuan, et al.
Publicado: (2022)

Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review
por: Kannapadi, Nivedha V., et al.
Publicado: (2022)

Clinicopathologic Characteristics of Grade 2/3 Meningiomas: A Perspective on the Role of Next-Generation Sequencing
por: Kim, Junhyung, et al.
Publicado: (2022)

Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma
por: Zhu, Hongda, et al.
Publicado: (2019)

High Tumor Mitochondrial DNA Content Correlates With an Improved Patient's Outcome in WHO Grade III Meningioma
por: Hua, Lingyang, et al.
Publicado: (2020)

TERT Alterations Predict Tumor Progression in De Novo High-Grade Meningiomas Following Adjuvant Radiotherapy
por: Deng, Jiaojiao, et al.
Publicado: (2021)

Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas
por: González-Tablas, María, et al.
Publicado: (2021)

Molecular Signatures of High-Grade Cervical Lesions
por: Porcari, Andreia M., et al.
Publicado: (2018)

Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling
por: Mei, Yu, et al.
Publicado: (2017)

Circulating Tumor Biomarkers in Meningiomas Reveal a Signature of Equilibrium Between Tumor Growth and Immune Modulation
por: Erkan, Erdogan Pekcan, et al.
Publicado: (2019)

WHO Grade I Meningioma Recurrence: Identifying High Risk Patients Using Histopathological Features and the MIB-1 Index
por: Haddad, Alexander F., et al.
Publicado: (2020)

Adjuvant Radiotherapy Versus Surveillance for Grade 2 Intracranial Meningiomas: A Multi-Institutional Propensity Score-Matched Study
por: Byun, Hwa Kyung, et al.
Publicado: (2022)

Performance comparison of 2D and 3D MRI radiomics features in meningioma grade prediction: A preliminary study
por: Duan, Chongfeng, et al.
Publicado: (2023)

Combined helical tomotherapy and Gamma Knife stereotactic radiosurgery for high-grade recurrent orbital meningioma: a case report
por: Zhang, Haomiao, et al.
Publicado: (2023)

An Overview of Managements in Meningiomas
por: Zhao, Lianhua, et al.
Publicado: (2020)

A Clinical Prognostic Model Based on Preoperative Hematological and Clinical Parameters Predicts the Progression of Primary WHO Grade II Meningioma
por: Gao, Peng, et al.
Publicado: (2021)

Development and Validation of Prognostic Nomogram in Patients With WHO Grade III Meningioma: A Retrospective Cohort Study Based on SEER Database
por: Jia, Zetian, et al.
Publicado: (2021)

Surgical and Peri-Operative Considerations for Brain Metastases
por: Gupta, Saksham, et al.
Publicado: (2021)

Corrigendum: An Overview of Managements in Meningiomas
por: Zhao, Lianhua, et al.
Publicado: (2020)

Recent Advances in Meningioma Immunogenetics
por: Al-Rashed, May, et al.
Publicado: (2020)

Identification and Management of Aggressive Meningiomas
por: Patel, Bhuvic, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_548f3nso134h5a31l7sl37p21g